Literature DB >> 20595635

Mast cells and Th17 cells contribute to the lymphoma-associated pro-inflammatory microenvironment of angioimmunoblastic T-cell lymphoma.

Claudio Tripodo1, Giorgia Gri, Pier Paolo Piccaluga, Barbara Frossi, Carla Guarnotta, Silvia Piconese, Giovanni Franco, Valeria Vetri, Carlo Ennio Pucillo, Ada Maria Florena, Mario Paolo Colombo, Stefano Aldo Pileri.   

Abstract

Reports focusing on the immunological microenvironment of peripheral T-cell lymphomas (PTCL) are rare. Here we studied the reciprocal contribution of regulatory (Treg) and interleukin-17-producing (Th17) T-cells to the composition of the lymphoma-associated microenvironment of angioimmunoblastic T-cell lymphoma (AITL) and PTCL not otherwise specified on tissue microarrays from 30 PTCLs not otherwise specified and 37 AITLs. We found that Th17 but not Treg cells were differently represented in the two lymphomas and correlated with the amount of mast cells (MCs) and granulocytes, which preferentially occurred in the cellular milieu of AITL cases. We observed that MCs directly synthesized interleukin-6 and thus contribute to the establishment of a pro-inflammatory, Th17 permissive environment in AITL. We further hypothesized that the AITL clone itself could be responsible for the preferential accumulation of MCs at sites of infiltration through the synthesis of CXCL-13 and its interaction with the CXCR3 and CXCR5 receptors expressed on MCs. Consistent with this hypothesis, we observed MCs efficiently migrating in response to CXCL-13. On these bases, we conclude that MCs have a role in molding the immunological microenvironment of AITL toward the maintenance of pro-inflammatory conditions prone to Th17 generation and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20595635      PMCID: PMC2913370          DOI: 10.2353/ajpath.2010.091286

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

Review 1.  Immunomodulatory mast cells: negative, as well as positive, regulators of immunity.

Authors:  Stephen J Galli; Michele Grimbaldeston; Mindy Tsai
Journal:  Nat Rev Immunol       Date:  2008-06       Impact factor: 53.106

2.  Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets.

Authors:  Pier Paolo Piccaluga; Claudio Agostinelli; Andrea Califano; Maura Rossi; Katia Basso; Simonetta Zupo; Philip Went; Ulf Klein; Pier Luigi Zinzani; Michele Baccarani; Riccardo Dalla Favera; Stefano A Pileri
Journal:  J Clin Invest       Date:  2007-02-15       Impact factor: 14.808

Review 3.  Regulatory T cells and cancer.

Authors:  Helen Y Wang; Rong-Fu Wang
Journal:  Curr Opin Immunol       Date:  2007-02-15       Impact factor: 7.486

4.  Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

Authors:  Nathalie Mourad; Nicolas Mounier; Josette Brière; Emmanuel Raffoux; Alain Delmer; Alfred Feller; Chris J L M Meijer; Jean-François Emile; Réda Bouabdallah; André Bosly; Jacques Diebold; Corinne Haioun; Bertrand Coiffier; Christian Gisselbrecht; Philippe Gaulard
Journal:  Blood       Date:  2008-02-21       Impact factor: 22.113

5.  International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

Authors:  Julie Vose; James Armitage; Dennis Weisenburger
Journal:  J Clin Oncol       Date:  2008-07-14       Impact factor: 44.544

6.  Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation.

Authors:  Pier Paolo Piccaluga; Claudio Agostinelli; Andrea Califano; Antonino Carbone; Luca Fantoni; Sergio Ferrari; Anna Gazzola; Annunziata Gloghini; Simona Righi; Maura Rossi; Enrico Tagliafico; Pier Luigi Zinzani; Simonetta Zupo; Michele Baccarani; Stefano A Pileri
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

7.  Evaluation of FoxP3 expression in peripheral T-cell lymphoma.

Authors:  Irina Bonzheim; Eva Geissinger; Marianne Tinguely; Sabine Roth; Tina Grieb; Peter Reimer; Martin Wilhelm; Andreas Rosenwald; Hans Konrad Müller-Hermelink; Thomas Rüdiger
Journal:  Am J Clin Pathol       Date:  2008-10       Impact factor: 2.493

Review 8.  New developments in mast cell biology.

Authors:  Janet Kalesnikoff; Stephen J Galli
Journal:  Nat Immunol       Date:  2008-11       Impact factor: 25.606

Review 9.  The master switch: the role of mast cells in autoimmunity and tolerance.

Authors:  Blayne A Sayed; Alison Christy; Mary R Quirion; Melissa A Brown
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 10.  Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.

Authors:  C Agostinelli; P P Piccaluga; P Went; M Rossi; A Gazzola; S Righi; T Sista; C Campidelli; P L Zinzani; B Falini; S A Pileri
Journal:  J Clin Pathol       Date:  2008-08-28       Impact factor: 3.411

View more
  25 in total

Review 1.  New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action?

Authors:  Margaret E Walker; Julianne K Hatfield; Melissa A Brown
Journal:  Biochim Biophys Acta       Date:  2011-02-25

Review 2.  Follicular helper T cells: implications in neoplastic hematopathology.

Authors:  Philippe Gaulard; Laurence de Leval
Journal:  Semin Diagn Pathol       Date:  2011-08       Impact factor: 3.464

Review 3.  The bone marrow stroma in hematological neoplasms--a guilty bystander.

Authors:  Claudio Tripodo; Sabina Sangaletti; Pier P Piccaluga; Sonam Prakash; Giovanni Franco; Ivan Borrello; Attilio Orazi; Mario P Colombo; Stefano A Pileri
Journal:  Nat Rev Clin Oncol       Date:  2011-03-29       Impact factor: 66.675

4.  CXCL13 levels are elevated in patients with Waldenström macroglobulinemia, and are predictive of major response to ibrutinib.

Authors:  Josephine M Vos; Nickolas Tsakmaklis; Christopher J Patterson; Kirsten Meid; Jorge J Castillo; Philip Brodsky; Tomas Ganz; Steven T Pals; Marie José Kersten; Lian Xu; Guang Yang; Steven P Treon; Zachary R Hunter
Journal:  Haematologica       Date:  2017-08-10       Impact factor: 9.941

5.  Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA.

Authors:  Marie-Hélène Delfau-Larue; Laurence de Leval; Bertrand Joly; Anne Plonquet; Dominique Challine; Marie Parrens; Alain Delmer; Gilles Salles; Franck Morschhauser; Richard Delarue; Pauline Brice; Reda Bouabdallah; Olivier Casasnovas; Hervé Tilly; Philippe Gaulard; Corinne Haioun
Journal:  Haematologica       Date:  2012-02-27       Impact factor: 9.941

6.  Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance.

Authors:  Preetesh Jain; Mohammad Javdan; Franziska K Feger; Pui Yan Chiu; Cristina Sison; Rajendra N Damle; Tawfiqul A Bhuiya; Filiz Sen; Lynne V Abruzzo; Jan A Burger; Andreas Rosenwald; Steven L Allen; Jonathan E Kolitz; Kanti R Rai; Nicholas Chiorazzi; Barbara Sherry
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

7.  Transcriptome sequencing reveals a profile that corresponds to genomic variants in Waldenström macroglobulinemia.

Authors:  Zachary R Hunter; Lian Xu; Guang Yang; Nicholas Tsakmaklis; Josephine M Vos; Xia Liu; Jie Chen; Robert J Manning; Jiaji G Chen; Philip Brodsky; Christopher J Patterson; Joshua Gustine; Toni Dubeau; Jorge J Castillo; Kenneth C Anderson; Nikhil M Munshi; Steven P Treon
Journal:  Blood       Date:  2016-06-14       Impact factor: 22.113

8.  Regulatory T cells enhance mast cell production of IL-6 via surface-bound TGF-β.

Authors:  Kirthana Ganeshan; Paul J Bryce
Journal:  J Immunol       Date:  2011-12-09       Impact factor: 5.422

9.  IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients.

Authors:  Milan Fiala; Madhuri Chattopadhay; Antonio La Cava; Eric Tse; Guanghao Liu; Elaine Lourenco; Ascia Eskin; Philip T Liu; Larry Magpantay; Stephen Tse; Michelle Mahanian; Rachel Weitzman; Jason Tong; Caroline Nguyen; Tiffany Cho; Patrick Koo; James Sayre; Otoniel Martinez-Maza; Mark J Rosenthal; Martina Wiedau-Pazos
Journal:  J Neuroinflammation       Date:  2010-11-09       Impact factor: 8.322

10.  The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation.

Authors:  Rossana Maffei; Jenny Bulgarelli; Stefania Fiorcari; Linda Bertoncelli; Silvia Martinelli; Carla Guarnotta; Ilaria Castelli; Silvia Deaglio; Giulia Debbia; Sara De Biasi; Goretta Bonacorsi; Patrizia Zucchini; Franco Narni; Claudio Tripodo; Mario Luppi; Andrea Cossarizza; Roberto Marasca
Journal:  Haematologica       Date:  2013-01-24       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.